OptimizeRx (OPRX) Long-Term Investments (2022 - 2024)

OptimizeRx has disclosed Long-Term Investments across 3 years of filings, most recently posting $434000.0 for Q2 2024.

• In Q2 2024, Long-Term Investments changed N/A year-over-year to $434000.0; the TTM figure through Jun 2024 stood at $434000.0 (changed N/A YoY), while the FY2023 annual figure was $568000.0, down 98.98% from the prior year.
• Long-Term Investments came in at $434000.0 for Q2 2024 at OptimizeRx, down from $501000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $55.9 million in Q4 2022 to a low of $434000.0 in Q2 2024.
• Average Long-Term Investments over 3 years is $11.6 million, with a median of $568000.0 recorded in 2023.
• The largest YoY upside for Long-Term Investments was 98.98% in 2023 against a maximum downside of 98.98% in 2023.
• Over 3 years, Long-Term Investments stood at $55.9 million in 2022, then slumped by 98.98% to $568000.0 in 2023, then dropped by 23.59% to $434000.0 in 2024.
• Per Business Quant data, the three most recent Long-Term Investments figures were $434000.0 in Q2 2024, $501000.0 in Q1 2024, and $568000.0 in Q4 2023.